The atrial natriuretic peptide (ANP) knockout mouse does not exhibit the phenotypic features of pre-eclampsia or demonstrate fetal growth restriction

被引：5
作者：
Finn-Sell, Sarah L. [1 ]
Renshall, Lewis J. [1 ]
Cowley, Elizabeth J. [1 ]
Dilworth, Mark R. [1 ]
Wareing, Mark [1 ]
Greenwood, Susan L. [1 ]
Sibley, Colin P. [1 ]
Cottrell, Elizabeth C. [1 ]
机构：
[1] Univ Manchester, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Maternal & Fetal Hlth Res Ctr,Inst Human Dev, Manchester M13 0JH, Lancs, England
来源：
PLACENTA | 2016年 / 42卷
关键词：
Pre-eclampsia; Fetal growth restriction; Atrial natriuretic peptide; Mouse; BLOOD-PRESSURE; TROPHOBLAST INVASION; ENOS-KNOCKOUT; MICE; HYPERTENSION; PATHOPHYSIOLOGY; MANAGEMENT; PREGNANCY;
D O I：
10.1016/j.placenta.2016.04.003
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The ANP knockout mouse is reported to exhibit pregnancy-associated hypertension, proteinuria and impaired placental trophoblast invasion and spiral artery remodeling, key features of pre-eclampsia (PE). We hypothesized that these mice may provide a relevant model of human PE with associated fetal growth restriction (FGR). Here, we investigated pregnancies of ANP wild type (ANP(+)/(+)), heterozygous (ANP(+/-)) and knockout (ANP(-/-)) mice. Maternal blood pressure did not differ between genotypes (E12.5, E17.5), and fetal weight (E18.5) was unaffected. Placental weight was greater in ANP(-/-) versus ANP(+/+) mice. Therefore, in our hands, the ANP model does not express phenotypic features of PE with FGR. (C) 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码：25 / 27
页数：3
相关论文
共 50 条
  • [21] Prediction of pre-eclampsia complicated by fetal growth restriction and its perinatal outcome based on an artificial neural network model
    Huang, Ke-Hua
    Chen, Feng-Yi
    Liu, Zhao-Zhen
    Luo, Jin-Ying
    Xu, Rong-Li
    Jiang, Ling-Ling
    Yan, Jian-Ying
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [22] Placental CLIC3 is increased in fetal growth restriction and pre-eclampsia affected human pregnancies
    Murthi, P.
    Stevenson, J. L.
    Money, T. T.
    Borg, A. J.
    Brennecke, S. P.
    Gude, N. M.
    PLACENTA, 2012, 33 (09) : 741 - 744
  • [23] Association of an Increased Risk of Pre-eclampsia and Fetal Growth Restriction in Singleton and Twin Pregnancies with Female Fetuses
    Bi Shilei
    Zhang Lizi
    Wang Zhijian
    Tang Jingman
    Xie Sushan
    Gong Jingjin
    Lin Lin
    Ren Luwen
    Huang Lijun
    Zeng Shanshan
    Chen Jingsi
    Du Lili
    Chen Dunjin
    母胎医学杂志（英文）, 2021, 03 (01) : 18 - 23
  • [24] Association of an Increased Risk of Pre-eclampsia and Fetal Growth Restriction in Singleton and Twin Pregnancies with Female Fetuses
    Bi, Shilei
    Zhang, Lizi
    Wang, Zhijian
    Tang, Jingman
    Xie, Sushan
    Gong, Jingjin
    Lin, Lin
    Ren, Luwen
    Huang, Lijun
    Zeng, Shanshan
    Chen, Jingsi
    Du, Lili
    Chen, Dunjin
    MATERNAL-FETAL MEDICINE, 2021, 3 (01) : 18 - 23
  • [25] Impact of fetal growth restriction on pregnancy outcome in women undergoing expectant management for preterm pre-eclampsia
    Cluver, C. A.
    Bergman, L.
    Bergkvist, J.
    Imberg, H.
    Geerts, L.
    Hall, D. R.
    Mol, B. W.
    Tong, S.
    Walker, S. P.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2023, 62 (05) : 660 - 667
  • [26] Unexplained fetal death, pre-eclampsia and fetal growth restriction in pregnancy: Who is screened for antiphospholipid syndrome?
    Gros, Clothilde
    Barral, Tiphaine
    Mageau, Arthur
    Nicaise, Pascale Roland
    Vivier, Valerie
    Papo, Thomas
    Bourgeois-Moine, Agnes
    Goulenok, Tiphaine
    Sacre, Karim
    THROMBOSIS RESEARCH, 2023, 228 : 61 - 63
  • [27] Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation
    Pilalis, A.
    Souka, A. P.
    Antsaklis, P.
    Daskalakis, G.
    Papantoniou, N.
    Mesogitis, S.
    Antsaklis, A.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2007, 29 (02) : 135 - 140
  • [28] A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction
    Ormesher, L.
    Johnstone, E. D.
    Shawkat, E.
    Dempsey, A.
    Chmiel, C.
    Ingram, E.
    Higgins, L. E.
    Myers, J. E.
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2018, 14 : 234 - 239
  • [29] Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation
    Papageorghiou, AT
    Yu, CKH
    Bindra, R
    Pandis, G
    Nicolaides, KH
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (05) : 441 - 449
  • [30] Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation
    Martin, AM
    Bindra, R
    Curcio, P
    Cicero, S
    Nicolaides, KH
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (06) : 583 - 586
12345